NUROW | tickerfilter.com

Fundamental analysis

52%

Profitability 60%

Dept financing 0%

Liquidity 0%

Performance 70%

Performance

5 Days

0 0%

1 Month

0 0%

3 Months

0 0%

6 Months

0 0%

1 Year

0 0%

2 Year

0 0%

Key data

Stock price

$0.14

P/E Ratio

N/A

DAY RANGE

$0.14 - $0.14

EPS

$0.00

52 WEEK RANGE

$0.01 - $0.10

52 WEEK CHANGE

-$71.43

MARKET CAP

103.702 K

YIELD

N/A

SHARES OUTSTANDING

2.736 M

DIVIDEND

N/A

EX-DIVIDEND DATE

N/A

NEXT EARNINGS DATE

N/A

BETA

0.00

PUBLIC FLOAT

AVERAGE 10 VOLUME

$10

AVERAGE 30 VOLUME

$417

Company detail

CEO: Shai N. Gozani
Region: US
Website: http://www.neurometrix.com
Employees: 0
IPO year: -

Issue type:
Market: NASDAQ
Industry: Medical Specialties
Sector: Health Technology

NeuroMetrix, Inc. is a healthcare company, which engages in the research, development, and trade of medical equipment and consumables. It offers an over-the-counter wearable therapeutic device for chronic pain, the Quell Health Cloud, DPNCheck, and pain management devices to treat chronic pain, nerve diseases, and sleep disorder. The company was founded by Shai N. Gozani in June 1996 and is headquartered in Woburn, MA.

NUROW - NeuroMetrix Inc Warrants 2015-27.5.20